Registro:

Referencias:

• Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., Global cancer statistics (2011) CA Cancer J Clin, 61, pp. 69-90
• Logothetis, C.J., Navone, N.M., Lin, S.H., Understanding the biology of bone metastases: Key to the effective treatment of prostate cancer (2008) Clin Cancer Res, 14, pp. 1599-1602
• Denmeade, S.R., Isaacs, J.T., A history of prostate cancer treatment (2002) Nat Rev Cancer, 2, pp. 389-396
• Rillahan, C.D., Paulson, J.C., Glycan microarrays for decoding the glycome (2011) Annu Rev Biochem, 80, pp. 797-823
• Dube, D.H., Bertozzi, C.R., Glycans in cancer and inflammation - Potential for therapeutics and diagnostics (2005) Nat Rev Drug Discov, 4, pp. 477-488
• Liu, F.T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nat Rev Cancer, 5, pp. 29-41
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335
• Levy, R., Biran, A., Poirier, F., Raz, A., Kloog, Y., Galectin-3 mediates crosstalk between K-Ras and Let-7c tumor suppressor microRNA (2011) PLoS ONE, 6, pp. e27490
• Ellerhorst, J., Troncoso, P., Xu, X.C., Lee, J., Lotan, R., Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer (1999) Urol Res, 27, pp. 362-367
• Van Den Brule, F.A., Waltregny, D., Liu, F.T., Castronovo, V., Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression (2000) Int J Cancer, 89, pp. 361-367
• Van Den Brule, F.A., Waltregny, D., Castronovo, V., Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients (2001) J Pathol, 193, pp. 80-87
• Valenzuela, H.F., Pace, K.E., Cabrera, P.V., White, R., Porvari, K., Kaija, H., O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1 (2007) Cancer Res, 67, pp. 6155-6162
• He, J., Baum, L.G., Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration (2006) Lab Invest, 86, pp. 578-590
• Ellerhorst, J.A., Stephens, L.C., Nguyen, T., Xu, X.C., Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP (2002) Prostate, 50, pp. 64-70
• Glinsky, V.V., Glinsky, G.V., Glinskii, O.V., Huxley, V.H., Turk, J.R., Mossine, V.V., Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium (2003) Cancer Res, 63, pp. 3805-3811
• Clausse, N., Van Den Brule, F., Waltregny, D., Garnier, F., Castronovo, V., Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion (1999) Angiogenesis, 3, pp. 317-325
• Fukumori, T., Oka, N., Takenaka, Y., Nangia-Makker, P., Elsamman, E., Kasai, T., Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer (2006) Cancer Res, 66, pp. 3114-3119
• Merseburger, A.S., Kramer, M.W., Hennenlotter, J., Simon, P., Knapp, J., Hartmann, J.T., Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer (2008) Prostate, 68, pp. 72-77
• Ahmed, H., Banerjee, P.P., Vasta, G.R., Differential expression of galectins in normal, benign and malignant prostate epithelial cells: Silencing of galectin-3 expression in prostate cancer by its promoter methylation (2007) Biochem Biophys Res Commun, 358, pp. 241-246
• Wang, Y., Nangia-Makker, P., Tait, L., Balan, V., Hogan, V., Pienta, K.J., Regulation of prostate cancer progression by galectin-3 (2009) Am J Pathol, 174, pp. 1515-1523
• Su, Z.Z., Lin, J., Shen, R., Fisher, P.E., Goldstein, N.I., Fisher, P.B., Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family (1996) Proc Natl Acad Sci U S A, 93, pp. 7252-7257
• Zick, Y., Eisenstein, M., Goren, R.A., Hadari, Y.R., Levy, Y., Ronen, D., Role of galectin-8 as a modulator of cell adhesion and cell growth (2004) Glycoconj J, 19, pp. 517-526
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251
• Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc Natl Acad Sci U S A, 104, pp. 13134-13139
• Ouyang, J., Juszczynski, P., Rodig, S.J., Green, M.R., O'Donnell, E., Currie, T., Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders (2011) Blood, 117, pp. 4315-4322
• Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma (2012) J Exp Med, 209, pp. 1985-2000
• Compagno, D., Merle, C., Morin, A., Gilbert, C., Mathieu, J.R., Bozec, A., SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas (2007) PLoS ONE, 2, pp. e1006
• Wiznerowicz, M., Trono, D., Conditional suppression of cellular genes: Lentivirus vector-mediated drug-inducible RNA interference (2003) J Virol, 77, pp. 8957-8961
• Gopalkrishnan, R.V., Roberts, T., Tuli, S., Kang, D., Christiansen, K.A., Fisher, P.B., Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related gene (2000) Oncogene, 19, pp. 4405-4416
• Le Mercier, M., Fortin, S., Mathieu, V., Roland, I., Spiegl-Kreinecker, S., Haibe-Kains, B., Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression (2009) Neoplasia, 11, pp. 485-496
• Thijssen, V.L., Barkan, B., Shoji, H., Aries, I.M., Mathieu, V., Deltour, L., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res, 70, pp. 6216-6224
• Karlou, M., Tzelepi, V., Efstathiou, E., Therapeutic targeting of the prostate cancer microenvironment (2010) Nat Rev Urol, 7, pp. 494-509
• Le, Q.T., Shi, G., Cao, H., Nelson, D.W., Wang, Y., Chen, E.Y., Galectin-1: A link between tumor hypoxia and tumor immune privilege (2005) J Clin Oncol, 23, pp. 8932-8941
• Zhao, X.Y., Chen, T.T., Xia, L., Guo, M., Xu, Y., Yue, F., Hypoxia inducible factor-1mediatesexpressionof galectin-1: Thepotential role inmigration/invasion of colorectal cancer cells (2010) Carcinogenesis, 31, pp. 1367-1375
• Ramsay, A.K., Leung, H.Y., Signalling pathways in prostate carcinogenesis: Potentials for molecular-targeted therapy (2009) Clin Sci, 117, pp. 209-228. , Lond
• Delgado, V.M., Nugnes, L.G., Colombo, L.L., Troncoso, M.F., Fernandez, M.M., Malchiodi, E.L., Modulation of endothelial cell migration and angiogenesis: A novel function for the "tandem-repeat" lectin galectin-8 (2011) FASEB J, 25, pp. 242-254
• Califice, S., Castronovo, V., Bracke, M., Van Den Brule, F., Dual activities of galectin-3 in human prostate cancer: Tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3 (2004) Oncogene, 23, pp. 7527-7536
• Lahm, H., André, S., Hoeflich, A., Fischer, J.R., Sordat, B., Kaltner, H., Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures (2001) J Cancer Res Clin Oncol, 127, pp. 375-386
• Thijssen, V.L., Hulsmans, S., Griffioen, A.W., The galectin profile of the endothelium: Altered expression and localization in activated and tumor endothelial cells (2008) Am J Pathol, 172, pp. 545-553
• Baum, L.G., Seilhamer, J.J., Pang, M., Levine, W.B., Beynon, D., Berliner, J.A., Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation (1995) Glycoconj J, 12, pp. 63-68
• Saussez, S., Camby, I., Toubeau, G., Kiss, R., Galectins as modulators of tumor progression in head and neck squamous cell carcinomas (2007) Head Neck, 29, pp. 874-884
• Lotan, R., Belloni, P.N., Tressler, R.J., Lotan, D., Xu, X.C., Nicolson, G.L., Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion (1994) Glycoconj J, 11, pp. 462-468
• Hsieh, S.H., Ying, N.W., Wu, M.H., Chiang, W.F., Hsu, C.L., Wong, T.Y., Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 27, pp. 3746-3753
• Banh, A., Zhang, J., Cao, H., Bouley, D.M., Kwok, S., Kong, C., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res, 71, pp. 4423-4431
• Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc Natl Acad Sci U S A, 103, pp. 15975-15980
• Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K.J., Galectin-3 induces endothelial cell morphogenesis and angiogenesis (2000) Am J Pathol, 156, pp. 899-909
• Markowska, A.I., Liu, F.T., Panjwani, N., Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response (2010) J Exp Med, 207, pp. 1981-1993

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------